Company Filing History:
Years Active: 2015-2020
Title: Innovations of Inventor Hideki Ueno
Introduction
Hideki Ueno is a notable inventor based in Plano, TX (US). He has made significant contributions to the field of immunology, particularly in the development of therapeutic antibodies. With a total of 3 patents, Ueno's work focuses on innovative methods for treating autoimmune and inflammatory conditions.
Latest Patents
One of Ueno's latest patents is centered around antagonistic anti-OX40L antibodies and methods of their use. This patent describes methods and compositions for treating autoimmunity and inflammatory conditions without non-specific suppression of the host immune system. The anti-OX40L antibodies are unique as they not only inhibit the differentiation of inflammatory T cells but also promote the generation and function of regulatory T cells. This is achieved by inducing IL-10 and inhibiting TNF-α, while also reducing aberrant Th2 cell responses. Furthermore, the methods and compositions aim to eliminate or reduce aberrant T follicular helper cell (Tfh) responses that may contribute to the pathogenicity of autoimmune diseases.
Career Highlights
Ueno is currently affiliated with Baylor Research Institute, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating complex autoimmune disorders.
Collaborations
Ueno collaborates with various professionals in his field, including his coworker SangKon Oh. Their combined expertise contributes to the development of groundbreaking therapeutic solutions.
Conclusion
Hideki Ueno's innovative work in the field of immunology, particularly with his patents on anti-OX40L antibodies, showcases his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for individuals suffering from autoimmune and inflammatory conditions.